On the underutilization of cardiac resynchronization therapy.
Alan J Bank1, Ryan M Gage1, Brian Olshansky2
1United Heart and Vascular Clinic, St Paul, Minnesota.
Journal of Cardiac Failure
|June 21, 2014
Summary
Cardiac resynchronization therapy (CRT) offers significant benefits for heart failure patients. Despite expanded guidelines, CRT device implantation rates remain stagnant, indicating potential underutilization of this vital treatment.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Cardiac resynchronization therapy (CRT) is indicated for specific heart failure patients.
- Recent guidelines have expanded CRT indications.
- CRT implant rates in the US have plateaued over the last 8 years.
Purpose of the Study:
- To review current CRT utilization data.
- To explore reasons for the underutilization of CRT.
- To provide recommendations for improving CRT use.
Main Methods:
- Analysis of existing clinical data and guidelines on CRT.
- Review of trends in CRT device implantation rates.
- Discussion of potential barriers to CRT adoption.
Main Results:
- Despite refined indications, CRT implant rates have not increased.
- A significant number of patients eligible for CRT are not receiving it.
- Underutilization may stem from various factors, including awareness and access.
Conclusions:
- CRT is an underutilized therapy for eligible heart failure patients.
- Addressing underutilization is crucial for improving patient outcomes.
- Recommendations focus on enhancing the proper and effective use of CRT.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
788
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
788
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
942
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
942
01:26Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
801
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
01:29Cardiomyopathy V: Interprofessional Care
750
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
750
01:22Heart Failure VI: Adjunct Therapies
631
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
631